Nick Thomas - Niche Editor
EMAIL: [email protected]
PHONE: 720.213.5824

Nick Thomas

Nick has an extensive journalism background, having worked in a variety of media and industries including as a reporter on the UK utilities sector for Bloomberg in London. He was also an early employee for successful digital M&A company Mergermarket where he served as the Content Editor. Originally from the UK, he has a BA in modern languages from the University of Wales (Bangor) and an MA in international studies from the University of Denver.


Canadian cannabis producer Organigram to list on Nasdaq

Organigram, a New Brunswick-based marijuana producer, will begin trading on the Nasdaq on May 21. The company will join other major Canadian producers listed on senior U.S. exchanges, such as Aurora Cannabis, Canopy Growth, Cronos and Tilray. Organigram will continue to maintain its TSX Ventures Exchange listing but will cease trading on U.S. over-the-counter markets […]

Read More

Marijuana firm Tilray revenue up nearly 200% in Q1; net loss grows on spending

Tilray, a British Columbia, Canada-based cannabis cultivator and distributor, reported revenue of $23 million for the first quarter of 2019, up 195% from the same period last year. The company’s net loss, however, widened nearly sixfold on higher spending. Tilray, which reports its earnings in U.S. dollars, said in a news release the sales gain […]

Read More

Acreage to sell cannabis real estate assets to newly formed REIT

New York-based marijuana company Acreage Holdings said it agreed to sell cannabis-related real estate to a newly formed real estate investment trust (REIT), GreenAcreage Real Estate Corp., under a leaseback agreement between the two companies. The price wasn’t disclosed. Acreage holds a 20% interest in GreenAcreage Real Estate Corp. (GARE). Acreage CEO Kevin Murphy also […]

Read More

Natura closes $91 million financing to build California marijuana campus

California-based Natura Life + Science announced the completion of a $91 million raise to build a marijuana campus in the Golden State. The 265,000-square-foot facility will eventually include a vertically integrated platform that includes cultivation, processing and dispensary operations, according to a news release. For more details about the raise, click here.

Read More

Marijuana company Columbia Care reports improved Q1 revenue, wider net loss

Columbia Care, a New-York based vertically integrated cannabis operator, reported revenue of $12.9 million for the first quarter ended March 31, 2019, up 45% from the same period last year thanks to “organic growth” and stronger consumer demand for its products. The net loss for the quarter widened to $25.1 million compared with a $9.7 […]

Read More

Missouri’s Triad Bank now offering services to cannabis businesses

Missouri’s medical marijuana industry has yet to launch, but that hasn’t stopped one local bank from stepping up to provide services. Triad Bank, based in St. Louis suburb Frontenac, is offering deposit services to marijuana-related businesses such as processors, cultivators and dispensaries, CEO Jim Regna told Marijuana Business Daily. The bank is well aware of […]

Read More

Marijuana group 4Front secures $50 million loan to help build facilities

Phoenix-based 4Front Holdings, a vertically integrated cannabis group, has secured a $50 million loan to help it build cultivation and production facilities connected with the company’s expected merger with Cannex Capital. The deal with Vancouver, British Columbia-based Cannex is awaiting final approval from U.S. antitrust authorities. The resulting combined entity is to be named 4Front […]

Read More

Epidiolex, Sativex maker GW Pharmaceuticals reports Q1 revenue, loss improvement

United Kingdom-based GW Pharmaceuticals showed revenue of $39.2 million for the quarter ended March 31, 2019, compared with $3 million in the same period a year ago. The maker of cannabis-derived medications, including Sativex and Epidiolex, recorded a net loss for the quarter of $50.1 million compared with a year-ago net loss of $69.5 million. […]

Read More

Multistate marijuana firm Curaleaf to expand into Ohio with $20 million acquisition

Massachusetts-based Curaleaf, which last week agreed to acquire Cura Partners for almost $1 billion, will expand into Ohio with the purchase of Ohio Grown Therapies. The $20 million deal, expected to close in the second half of 2019, includes the acquisition of Johnstown-based Ohio Grown Therapies’ cultivation and processing facilities and licenses. For more details, click […]

Read More